AbbVie Slams FTC's Bid To Review Pay-For-Delay Ruling
A recent appellate court decision has no real bearing on the Federal Trade Commission's pay-for-delay case against AbbVie Inc. and other drugmakers, the companies told a Pennsylvania federal judge Friday, urging...To view the full article, register now.
Already a subscriber? Click here to view full article